Review of Pulmonary Arterial Hypertension (PAH) Management

Monday, May 1, 2023, 12:00 AM - Wednesday, May 1, 2024, 12:00 AM

Released 5/1/2023 --- Expires 5/1/2024 --- Estimated Time to Complete: 45 minutes

1. Review the pathophysiology of pulmonary arterial hypertension (PAH)
2. Review PAH medications and treatment guidelines
3. Evaluate clinical efficacy and safety of current medication therapies available
4. Identify functional classifications of PAH
5. Recognize the medications available for the treatment of PAH
6. Discuss the importance of medication management in PAH

Beaumont Employees: $0

This module is restricted to Beaumont (Corewell Health East) employees only.

Pharmacist CE (ACPE) (0.75 hours), Pharmacy Technician CE (ACPE) (0.75 hours)

In support of improving patient care, Beaumont Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacist and Pharmacy Technician CE: Beaumont Health designates this activity for 0.75 ACPE contact hour(s). ACPE Universal Activity Number (UAN): JA4008259-0000-23-103-H01-P; JA4008259-0000-23-103-H01-T.  Pharmacists and pharmacy technicians should claim only the credit commensurate with the extent of their participation in the activity.  Credit will be uploaded to the NABP CPE Monitor within 30 days after the activity completion.  Per ACPE rules, Beaumont Health does not have access nor the ability to upload credits requested after the evaluation closes.  It is the responsibility of the pharmacist or pharmacy technician to provide the correct information (NABP ID and DOB (MMDD) to receive credit.

All individuals involved with this module have no relevant financial relationships with ineligible companies to disclose.

Mitigation of Relevant Financial Relationships

Beaumont Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.